Profilaksa DVT kod velikih ortopedskih operacija - Depol ...

72
2 st INTERNATIONAL CONFERENCE ON REGENERATIVE ORTHOPAEDICS
Institution
Mayo Clinic
Field of research
Regenerative medicine
Cardiovascular medicine
Stem cell biology
Andre Terzic
MD, PhD, Professor of Medicine and Pharmacology
Director, Center for Regenerative Medicine; Mayo Clinic
ROCHESTER, MN, USA
terzic.andre@mayo.edu
Scientific Work
Behfar A, Terzic A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields functional
cardiac progeny. Nature Clin Pract Cardiovasc Med 2006.
Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederlander NJ, Behfar A, Terzic A. Stem cell transformation
into cardiac phenotype guided by directed remodeling of nuclear transport machinery. Nature Clin Pract Cardiovasc
Med, 2007
Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederländer N, Alekseev AE,
Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med
2007.
Nelson TJ, Martinez-Fernandez A, Terzic A. Induced pluripotent stem cells: developmental biology to regenerative
medicine. Nature Cardiol Rev, 2010.
Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic
oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming.
Cell Metab, 2011
Membership of Scientific Societies and/or Associations
Past President, American Society for Clinical Pharmacology and Therapeutics
Chair, Functional Genomics and Translational Biology Council, American Heart Association
Chair, Scientific Advisory Board, International Society for Cardiovascular Translational Research